Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status final results of a phase 2 study (Burkimab)
Identifiers
Identifiers
Services
Services
Date issued
2013Journal title
CANCER
Type of content
Artigo
